With its outstanding investment team and high-conviction multimanager approach, Primecap Odyssey Aggressive Growth is exemplary within the mid-growth Morningstar Category.
PRIMECAP Odyssey Aggressive Growth POAGX
- NAV / 1-Day Return 41.57 / −1.26 %
- Total Assets 6.7 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.660%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.02%
- Turnover 5%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0
Morningstar’s Analysis POAGX
Will POAGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 31.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Dreyfus Treasury Secs Cash Mgmt Inst | 5.04 | 362.5 Mil | Corporate |
Eli Lilly and Co | 4.90 | 351.8 Mil | Healthcare |
Splunk Inc | 3.61 | 259.5 Mil | Technology |
Micron Technology Inc | 3.51 | 252.1 Mil | Technology |
Rhythm Pharmaceuticals Inc | 3.30 | 237.5 Mil | Healthcare |
Biogen Inc | 3.16 | 227.0 Mil | Healthcare |
Sony Group Corp ADR | 2.78 | 199.9 Mil | Technology |
Biomarin Pharmaceutical Inc | 2.60 | 186.7 Mil | Healthcare |
Tesla Inc | 2.48 | 178.6 Mil | Consumer Cyclical |
Flex Ltd | 2.47 | 177.2 Mil | Technology |